Good to see progress on some trials but in relation to GVHD "expected to commence" sounds a little ominous .... perhaps CYP are in fact waiting for another biotech's response from the FDA given how many times the trial has been postponed ?
Ann: Strategic Review of Cynata Clinical Development Portfolio, page-3
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
-0.025(8.62%) |
Mkt cap ! $47.60M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 28.5¢ | 26.5¢ | $30.17K | 112.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 28895 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |